Navigation Links
Johannes N. van den Anker, MD, PhD, Prominent Neonatal and Pediatric Clinical Pharmacologist, Joins NDA Partners
Date:5/15/2019

NDA Partners Chairman Carl Peck, MD, announced today that Johannes N. van den Anker, MD, PhD, a prominent neonatal and pediatric clinical pharmacologist and expert in pediatric and neonatal clinical trials and therapies, has joined the firm as an Expert Consultant.

Dr. van den Anker is Vice Chair of Pediatrics for Experimental Therapeutics, the Evan and Cindy Jones Chair in Pediatric Clinical Pharmacology, and serves as Director of the Division of Clinical Pharmacology at Children’s National Medical Center (Washington, DC). He is Professor of Pediatrics, Pharmacology & Physiology, and Genomics and Precision Medicine at The George Washington University (Washington, DC). He is also the Eckenstein-Geigy Distinguished Professor of Pediatric Pharmacology and Department Chair of Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital (Basel, Switzerland), and Adjunct Professor of Medicine, Pediatrics, Pharmacology and Molecular Sciences at Johns Hopkins University School of Medicine (Baltimore, MD), and Adjunct Faculty, Intensive Care and Department of Surgery, Erasmus MC-Sophia Children’s Hospital (Rotterdam, the Netherlands). In addition to his research positions, Dr. van den Anker serves as the part-time Chief Medical Officer of ReveraGen BioPharma.

Dr. van den Anker formerly served as Director, Division of Neonatology at Sophia Children’s Hospital and as Director, Division of Pediatric Clinical Pharmacology and Medical Toxicology, at Columbus Children’s Hospital (Columbus, Ohio).

“Dr. van den Anker’s extensive knowledge of pediatric and neonatal clinical pharmacology and expertise in pediatric and neonatal therapies and clinical trials makes him an outstanding resource for assisting our clients in the design and implementation of their pediatric development programs,” said Dr. Peck. “We are delighted that he has joined NDA Partners team of Expert Consultants.”

Dr. van den Anker received his medical degree and Doctorate in Pharmacology from Erasmus University Rotterdam in Rotterdam, the Netherlands. He completed his residency in Pediatrics and a fellowship in Neonatology at Sophia Children’s Hospital in the Netherlands.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners(dot)com

Read the full story at https://www.prweb.com/releases/johannes_n_van_den_anker_md_phd_prominent_neonatal_and_pediatric_clinical_pharmacologist_joins_nda_partners/prweb16304383.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. HyGreen Partners with RCA Medical in Johannesburg, South Africa
2. NeuroCog Trials Appoints Health Care Banker, Josh Spiegel, CFA To Chief Operating Officer
3. Prominent Speakers Offer Lessons for Health and Health Care Quality Innovators
4. SMi Group Reports: 16 Prominent Updates in Pre-Filled Syringes by Big Pharma and Industry Innovators
5. The Access Group Recognized for Oncology Leadership: Agencys Oncology Business Unit Receives Praise from Prominent Industry Publication
6. Mauna Kea Technologies Cellvizio Featured Prominently at 2016 World Congress for Bronchology and Interventional Pulmonology
7. Prominent Physicians Join Juniper Pharmaceuticals Scientific Advisory Board
8. Landmark Trial Entitled "PROMINENT" To Explore The Prevention Of Heart Disease In Diabetic Patients With High Triglycerides And Low HDL-C
9. OncoSec to Present at Prominent Investment Conferences in January
10. Precision for Value Adds Prominent Health Economist Dr. Christopher Blanchette to its Expanding HEOR Team
11. New Study Suggests Prominent Role for Pharmacies In Reducing Asthma-related Illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... ... 2019 , ... The Cohen Veterans Network (CVN), ... its next three Steven A. Cohen Military Family Clinics opening this ... to more than 11,000 clients, with a focus on serving post-9/11 veterans and ...
(Date:5/22/2019)... ... 22, 2019 , ... Strive Health and its sister company, ... Psychiatric Association president-elect Jeffrey Geller, MD to its Board of Advisors. , ... largest psychiatric association in the world with more than 37,800 physician members specializing ...
(Date:5/22/2019)... TORONTO (PRWEB) , ... May 22, 2019 , ... ... E6R2 guidelines for good clinical practice, reflecting a changing culture of risk-based quality ... challenges in implementing these guidelines into their existing clinical trial portfolios. Cloud-based technology ...
Breaking Medicine Technology:
(Date:5/22/2019)... ... May 22, 2019 , ... In collaboration with the ... 2019 Mind the Workplace report, which explored the relationships between supervisor ... wellbeing. , The findings showed that supervisor communication and a company ...
(Date:5/22/2019)... CINCINNATI (PRWEB) , ... May 22, 2019 , ... Lakota ... ‘tunable’ prosthetic for a 5-year-old girl who was born without her right hand. ... Hansika Hamre’s hands and forearms in order to replicate the geometries needed to design ...
(Date:5/21/2019)... ... May 21, 2019 , ... In ... the 2015 21st Century Cure Act[2], calls for the identification and refinement of ... records. The American Medical Informatics Association; however, recommends that healthcare researchers and providers ...
(Date:5/21/2019)... ... 2019 , ... Dr. Mauricio Martinez and the team at Gulf Coast Smiles ... as common symptoms to look out for including daytime fatigue and snoring ... apnea and treats the condition with guided lifestyle changes, oral appliance therapy, and CPAP ...
(Date:5/21/2019)... ... ... • Trailer: https://youtu.be/bDf15sO5F2M , Assets and Press ... , Black Box VR, a pioneer in virtual reality fitness and BEST ... San Francisco, California. Located across the street from Uber and Twitter headquarters on Market ...
Breaking Medicine News(10 mins):